Lu-177-DOTATATE Peptide Receptor Radionuclide Therapy

被引：3
|
作者：
Abbott, Amanda
Jacene, Heather
机构：
来源：
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | 2018年 / 46卷 / 03期
关键词：
D O I：
10.2967/jnmt.118.217844
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：245 / 246
页数：2
相关论文
共 50 条
  • [1] Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review
    Nautiyal, Amit
    Michopoulou, Sofia
    Guy, Matt
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2024, 12 (02) : 157 - 175
  • [2] Dosimetry in Lu-177-DOTATATE peptide receptor radionuclide therapy: a systematic review
    Amit Nautiyal
    Sofia Michopoulou
    Matt Guy
    [J]. Clinical and Translational Imaging, 2024, 12 : 157 - 175
  • [3] Survey of Early Adopters of Peptide Receptor Radionuclide Therapy with Lu-177-dotatate in the USA
    Slonimsky, Einat
    Tulchinsky, Mark
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [4] Outcome analysis in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy with Lu-177-DOTATATE
    Pretot, Dominique
    Engel-Bicik, Ivette
    Kenkel, David
    Kaufmann, Philipp A.
    Treyer, Valerie
    Siebenhuner, Alexander R.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (03) : 1204 - 1217
  • [5] Peptide Receptor Radionuclide Therapy by 177Lu-DOTATATE of a Secreting Cervical Paraganglioma
    Deville, Agathe
    Pinigina, Iuliia
    Al Mansour, Laure
    Abeillon, Juliette
    Tordo, Jeremie
    [J]. CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E71 - E73
  • [6] In Vivo Instability of 177Lu-DOTATATE During Peptide Receptor Radionuclide Therapy
    Lubberink, Mark
    Wilking, Helena
    Ost, Amalia
    Ilan, Ezgi
    Sandstrom, Mattias
    Andersson, Camilla
    Fross-Baron, Katarzyna
    Velikyan, Irina
    Sundin, Anders
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (09) : 1337 - 1340
  • [7] 177Lu DOTATATE nanoparticles: A therapeutic option for peptide receptor radionuclide therapy
    Arora, Geetanjali
    Shukla, Jaya
    Ghosh, Sourabh
    Malhotra, Arun
    Bandohpadhyaya, Guru
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [8] Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE; dosimetric findings
    Mok, S.
    Tay, Y.
    Ng, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
  • [9] Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE in Carcinoid Heart Disease: A Contraindication or a Promising Treatment Approach Bettering Chances for Corrective Surgery?
    Ramesh, Sudha
    Kudachi, Shreyas
    Basu, Sandip
    [J]. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2018, 46 (03) : 292 - 294
  • [10] Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE in a Murine Model of a Human Neuroendocrine Tumor
    Wu, Yin
    Pfeifer, Andreas Klaus
    Myschetzky, Rebecca
    Garbyal, Rajendra Singh
    Rasmussen, Palle
    Knigge, Ulrich
    Bzorek, Michael
    Kristensen, Michael Holmsgaard
    Kjaer, Andreas
    [J]. DIAGNOSTICS, 2013, 3 (04): : 344 - 355
12345